Alphanate AHF/VWF Complex
|
Manufacturer: Grifols
|
| Generic
Name: Antihemophilic
Factor / von Willebrand Factor
Complex |
Indications: - Hemophilia A or Acquired
Factor VIII Deficiency:
Antihemophilic Factor/von
Willebrand Factor Complex
(Human), Alphanate,
is indicated for the prevention and control of bleeding in patients with Factor VIII deficiency due to Hemophilia A or acquired Factor VIII deficiency.
-
von Willebrand Disease:
Antihemophilic
Factor/von Willebrand
Factor Complex (Human),
Alphanate, is also
indicated for surgical and/or invasive procedures in patients with von Willebrand Disease in whom desmopressin (DDAVP)
is either ineffective or
contraindicated. It is
not indicated for patients
with severe VWD (Type 3)
undergoing major surgery.
|
| How
Supplied: Factor
products are supplied in vials
sizes of varying International
Units (iu). Vial sizes (iu
sizes) may change with each new
lot of product manufactured.
Vial sizes may range from
approximately 200 - 1500 iu per
vial. |
| |
|
Available Sizes |
Size |
NDC Numbers |
PI |
MSDS |
|
Alphanate
AHF/VWF |
250iu vial
|
68516-4601-01 |
PI |
MSDS |
|
Alphanate
AHF/VWF |
500iu vial |
68516-4602-01 |
PI |
MSDS |
|
Alphanate
AHF/VWF |
1000iu vial |
68516-4603-02 |
PI |
MSDS |
|
Alphanate
AHF/VWF |
1500iu vial |
68516-4604-02 |
PI |
MSDS |
| |
| Clinical Data: For any questions
or for further information
related to Alphanate, Antihemophilic Factor/von Willebrand Factor Complex
(Human), clinical pharmacology, additional
indications and usages, contraindications, warnings, precautions,
adverse reactions, dosage, administration and/or storage of this
product, please contact
BDI Pharma or call 1-800-948-9834. |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|